What smart money is saying about Stevanato Group SpA
2 funds in our archive have pitched Stevanato Group SpA — most recently Artisan U.S. Small-Cap Growth Strategy in December 2025.
Stevanato Group S.p.A. engages in the design, production, and distribution of products and processes to provide integrated solutions for pharma and healthcare. Its principal products include containment solutions, drug delivery systems, medical devices, diagnostic, analytical services, visual inspection machines, assembling and packaging machines, and glass forming machines. The company was founded in 1949 and is headquartered in Piombino Dese, Italy. Stevanato Group S.p.A. operates as a subsidiary of Stevanato Holding S.R.L.
Fund coverage · 2 theses
- Artisan U.S. Small-Cap Growth StrategyDecember 2025
Stevanato Group SpA is a health care packaging and machinery leader positioned to benefit from liquid biologics growth and broader GLP-1 coverage despite near-term uncertainty.
Read the full thesis - Artisan US Small Cap Growth StrategyJune 2025
Stevanato is a leading provider of specialty glass and plastic packaging for the health care industry, poised for attractive earnings growth driven by a shift to higher margin products and the expansion of biologic drugs.
Read the full thesis
Read every full thesis on Stevanato Group SpA
Unlock all 2 theses — the full reasoning behind what funds are buying, plus unlimited access to the entire archive.
View plans→